US Patent 7115601 HIV integrase inhibitors
Patent 7115601 was granted and assigned to Bristol-Myers Squibb on October, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+272 characters)
Article
Patent abstract
Compounds of the present disclosure are spirocycle-substituted pyrimidinecarboxamides. Also disclosed are pharmaceutical compositions comprising the compounds, and methods of using the compounds. The compounds are useful for treating HIV infection and AIDS.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07115601 HIV integrase inhibitors US Patent 7115601 HIV integrase inhibitors
Infobox
Patent Number
0711560100
Patent Number
711560100
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071156010
Date of Patent
October 3, 2006
0Patent Application Number
111278780
Date Filed
May 12, 2005
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071156010
Date of Patent
October 3, 2006
0Patent Application Number
111278780
Date Filed
May 12, 2005
0Official Website
Patent Primary Examiner
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 17 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07115601 HIV integrase inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07115601
Date of patent
October 3, 2006
Patent application number
11127878
Date Filed
May 12, 2005
Patent primary examiner
Find more entities like US Patent 7115601 HIV integrase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
